Pediatric Septic Arthritis 

  • Author: Richard J Scarfone, MD; Chief Editor: Robert W Tolan Jr, MD   more...
 
Updated: Jul 29, 2011
 

Background

Background

Septic arthritis (SA) results from the presence of microbial agents in a joint space. SA of the hip is a true orthopedic emergency; delay in diagnosis or treatment may result in irreversible damage to the joint. In recent decades, the relative frequency with which specific microbial agents have been causing infection has dramatically decreased, resulting in a decline in the overall incidence of SA and a modification in the presumptive medical therapy.

SA is a challenging clinical problem because (1) signs and symptoms may be subtle and overlap with those found in other conditions, (2) screening laboratory studies and synovial fluid cultures are relatively insensitive, and (3) optimal management, including duration of antibiotics and surgical approach, is not evidence based. (See the image below.) (See History, Physical Examination, Workup, Treatment, and Medication.)

Emergency room photograph of an infant with septicEmergency room photograph of an infant with septic arthritis of the left hip. The child holds his hip rigidly in the classic position of flexion, abduction, and external rotation, a position that maximizes capsular volume. The patient is relatively comfortable as long as the hip joint remains immobile in this position.

Patient education

Nontraumatic joint pain with evidence of arthritis, such as swelling, warmth, or redness, requires emergency medical attention. For patient education information, see the Arthritis Center, as well as Knee Pain.

Next

Etiology

The most common route by which microorganisms enter a joint is by hematogenous spread to the synovium. Less commonly, entry occurs directly following a penetrating trauma or contiguously from an adjacent osteomyelitis. Because of their unique anatomy, neonates and young children often have coexisting septic arthritis and osteomyelitis. The bony cortex is thin, and the periosteum is loose. Blood vessels that connect the metaphysis and epiphysis serve as a conduit by which bony infection may easily reach the joint space.

Proteolytic enzymes released by inflammatory cells can damage joint cartilage. In addition, inflammatory mediators, bacteria, and pus increase pressure within the joint, compress intra-articular vessels, and impair blood supply to the cartilage and adjacent bone. Pressure necrosis within any joint may destroy synovium or cartilage, but septic arthritis of the hip is a true orthopedic emergency. In the hip, if the condition remains undiagnosed and untreated, contiguous spread may cause ligamentous damage, avascular necrosis of the femoral head, dislocation, and osteomyelitis.

Infectious agents

In neonates (aged < 2 mo), Staphylococcus aureus is the most common cause of septic arthritis (SA), but Escherichia coli, group B streptococci, and other gram-negative bacilli also cause the disease.

In children aged 2 months to 5 years, Haemophilus influenzae type B was the most common cause of SA prior to the widespread use of vaccines; S aureus is now the most common cause. In a series of 61 children diagnosed with a known pathogen from 1975-1985, H influenzae type B caused the infection in about half of the children.[1] In contrast, among 46 children diagnosed with septic arthritis from 2000-2006, S aureus was the cause in 31 (67%).[2] Other etiologies include group A streptococci and Streptococcus pneumoniae. Community-acquired methicillin-resistant S aureus (MRSA-CA) is an increasingly common cause of SA in children.

In adolescents, Neisseria gonorrhoeae is the suspected cause for patients with either polyarticular or monoarticular disease. Group A streptococcus is reported in numerous children with active varicella-zoster infection. Salmonella is suspected in individuals with sickle cell anemia.

Mycobacterium tuberculosis is a rare cause of chronic pyogenic arthritis. If identifiable risk factors are present, then a purified protein derivative (PPD) should be placed for the child with culture-negative disease. Kingella kingae has been noted to cause SA in children younger than 5 years in Israel and is an emerging pathogen in the United States. Rarely, fungi or anaerobes may be found within a septic joint.

A common cause of reactive arthritis is the spirochete Borrelia burgdorferi. Children typically present with a monoarthritis, in the absence of fever, weeks to months after being bitten by a tick. Less common causes of reactive arthritis include mycoplasma and viruses.

Previous
Next

Epidemiology

Occurrence in the United States

Septic arthritis (SA) is more common in children than adults, but the actual incidence is unknown. From 1979-1996, a tertiary-care children's hospital reported just 82 children with either confirmed or suspected SA of the hip.[3] From 2000-20004, 34 such cases were diagnosed at a tertiary-care children's hospital.[4] Data from older studies are somewhat obsolete, because effective vaccines have virtually eliminated the most common etiologic agent, Haemophilus influenzae type B.

With the dramatic increase in MRSA-CA, the clinical impression of pediatricians and pediatric emergency medicine physicians is that a corresponding increase in the incidence of SA has been observed.[5] Large, population-based studies to prove this trend are lacking.

Subgroups of children who are at high risk for SA include neonates, individuals with hemophilia who are subject to hemarthrosis, and individuals who are immunocompromised, such as those with sickle cell anemia or human immunodeficiency virus (HIV) infection or those treated with chemotherapy.

Sex- and age-related demographics

A higher incidence of SA is reported among boys than girls; some series report that boys are affected twice as frequently as are girls. However, a series of 82 children with SA of the hip found no sex predilection.[3]

SA occurs among all age groups but is most common in younger children, peaking in those younger than age 3 years.

Previous
Next

Prognosis

Time to diagnosis is the most important prognostic factor in septic arthritis (SA). Early institution of therapy helps to prevent degenerative arthritis. Diagnosis may be delayed in young infants, which leads to a poorer outcome.

Other poor prognostic factors include infection of the hip joint, which may lead to aseptic necrosis of the femoral head; infection with S aureus; and a prolonged passage of time before the synovial fluid is sterilized.

Meningitis (10-30%), osteomyelitis (5-10%), cellulitis (10-30%), and pneumonia (5%) are potential complications in young children with septic arthritis resulting from hematogenous spread of H influenzae type B. Osteonecrosis, growth arrest, and sepsis are potential complications from SA of any etiology.

Because of the availability of antibiotics, children rarely die from septic arthritis or its complications. Although chronic arthritis is uncommon, the short-term morbidity and costs, in terms of prolonged antibiotic therapy and hospitalizations, may be substantial.

Previous
 
 
Contributor Information and Disclosures
Author

Richard J Scarfone, MD  Associate Professor, Department of Pediatrics, University of Pennsylvania School of Medicine; Attending Physician, Division of Emergency Medicine and Medical Director of Emergency Preparedness, The Children's Hospital of Philadelphia

Richard J Scarfone, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Pediatrics

Disclosure: Nothing to disclose.

Specialty Editor Board

Itzhak Brook, MD, MSc  Professor, Department of Pediatrics, Georgetown University School of Medicine

Itzhak Brook, MD, MSc is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, Armed Forces Infectious Diseases Society, Association of Military Surgeons of the US, Infectious Diseases Society of America, International Immunocompromised Host Society, International Society for Infectious Diseases, Medical Society of the District of Columbia, New York Academy of Sciences, Pediatric Infectious Diseases Society, Society for Ear, Nose and Throat Advances in Children, Society for Experimental Biology and Medicine, Society for Pediatric Research, Southern Medical Association, and Surgical Infection Society

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Joseph Domachowske, MD  Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York Upstate Medical University

Joseph Domachowske, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Chief Editor

Robert W Tolan Jr, MD  Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine

Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility

Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; Sanofi Pasteur Honoraria Speaking and teaching; Baxter Healthcare Honoraria Speaking and teaching; Novartis Honoraria Speaking and teaching

References
  1. Welkon CJ, Long SS, Fisher MC, Alburger PD. Pyogenic arthritis in infants and children: a review of 95 cases. Pediatr Infect Dis. Nov-Dec 1986;5(6):669-76. [Medline].

  2. Thompson A, Mannix R, Bachur R. Acute pediatric monoarticular arthritis: distinguishing lyme arthritis from other etiologies. Pediatrics. Mar 2009;123(3):959-65. [Medline].

  3. Kocher MS, Zurakowski D, Kasser JR. Differentiating between septic arthritis and transient synovitis of the hip in children: an evidence-based clinical prediction algorithm. J Bone Joint Surg Am. Dec 1999;81(12):1662-70. [Medline].

  4. Caird MS, Flynn JM, Leung YL, et al. Factors distinguishing septic arthritis from transient synovitis of the hip in children. A prospective study. J Bone Joint Surg Am. Jun 2006;88(6):1251-7. [Medline].

  5. Kaplan SL. Challenges in the evaluation and management of bone and joint infections and the role of new antibiotics for gram positive infections. Adv Exp Med Biol. 2009;634:111-20. [Medline].

  6. Taekema HC, Landham PR, Maconochie I. Towards evidence based medicine for paediatricians. Distinguishing between transient synovitis and septic arthritis in the limping child: how useful are clinical prediction tools?. Arch Dis Child. Feb 2009;94(2):167-8. [Medline].

  7. [Guideline] Fordham L, Gunderman R, Blatt ER, et al. Limping child--ages 0-5 years. American College of Radiology (ACR). 2007;5. [Full Text].

  8. Pääkkönen M, Kallio MJ, Peltola H, Kallio PE. Pediatric septic hip with or without arthrotomy: retrospective analysis of 62 consecutive nonneonatal culture-positive cases. J Pediatr Orthop B. May 2010;19(3):264-9. [Medline].

Previous
Next
 
Emergency room photograph of an infant with septic arthritis of the left hip. The child holds his hip rigidly in the classic position of flexion, abduction, and external rotation, a position that maximizes capsular volume. The patient is relatively comfortable as long as the hip joint remains immobile in this position.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.